Deals Shaping the Medical Industry (2/2012)
Executive Summary
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
You may also be interested in...
Swiss Initiative To Monitor Missing Medical Devices To Manage Current Product Crisis
The ongoing availability of many medical devices in Switzerland is threatened even more severely than in the EU. Medtech Insight spoke to two key life science experts to understand why this is and to hear the solutions they are proposing.
Minute Insight: Intel-Penn Tie-Up Proves Federated Approach’s Power
Federated learning has taken another step forward thanks to new research that proves it is better at spotting brain tumors.
EU Data Act Must Consider ‘Sectoral Peculiarities’ Says Medtech Industry
The European Commission’s proposed Data Act is among a growing pile of horizontal regulations set to impact the medtech industry. But changes should be made to protect trade secrets and other sector-specific nuances, MedTech Europe warns.